Clinical Trial Update: The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether Coleus Forskohlii extract can improve risk factors related to metabolic syndrome and obesity. The current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• Coleus Forskohlii Extract (forskolin)

Snippet

Sponsor: Olive Lifesciences Pvt Ltd | Conditions: Metabolic Syndrome, Obesity | Phase 3 | Status: UNKNOWN